Literature DB >> 8142007

Hemoglobins with multiple reactive sulphydryl groups: the reaction of pigeon hemoglobin with 5,5'-dithiobis (2-nitrobenzoic acid).

K O Okonjo1, T O Okia.   

Abstract

Pigeon hemoglobin has eight reactive sulphydryl groups per (tetramer) molecule, as determined by Boyer titration with p-chloromercuribenzoate. However, only four of these are titratable with 5,5'-dithiobis(2-nitrobenzoate) under the same experimental conditions. The time course of the reaction of pigeon hemoglobin with 5,5'-dithiobis(2-nitrobenzoate) is biphasic. In the pH range 6-9, the fast phase is between one and two orders of magnitude faster than the slow phase. For the fast phase, kapp, the apparent second-order rate constant, increases monotonously with pH. Quantitative analysis reveals that the reaction of the sulphydryl group responsible for this phase is coupled to the ionization of two groups with pKa values of 6.15 +/- 0.1 and 8.5 +/- 0.1. These pKa values are assigned to HisHC3(146) beta and to the CysF9(93) beta sulphydryl group, respectively. For the slow phase the kapp vs. pH profiles are bowl-shaped. Analysis reveals that the reaction of the sulphydryl group to which this phase may be attributed is coupled to the ionization of two groups with mean pKa values of 6.53 +/- 0.1 and 8.25 +/- 0.1. Examination of the structure of hemoglobin allows us to assign these values to HisG19(117) beta and CysB5(23) beta, respectively. The CysB5(23) beta sulphydryl is in the region of the molecule where amino acid substitutions have been found to give rise to significant changes in the oxygen affinity of hemoglobin [Huang et al. (1990), Biochemistry 29, 7020-7023].

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8142007     DOI: 10.1007/bf01025129

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  21 in total

1.  Ionizable groups linked to the reaction of 2,2'-dithiobispyridine with hemoglobin.

Authors:  K O Okonjo; C O Aboluwoye
Journal:  Biochim Biophys Acta       Date:  1992-10-20

2.  Structure and function of hemoglobin variants at an internal hydrophobic site: consequences of mutations at the beta 27 (B9) position.

Authors:  Y Huang; J Pagnier; P Magne; F Baklouti; J Kister; J Delaunay; C Poyart; G Fermi; M F Perutz
Journal:  Biochemistry       Date:  1990-07-31       Impact factor: 3.162

3.  Structure of horse carbonmonoxyhaemoglobin.

Authors:  E J Heidner; R C Ladner; M F Perutz
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

4.  Influence of globin structure on the state of the heme. II. Allosteric transitions in methemoglobin.

Authors:  M F Perutz; A R Fersht; S R Simon; G C Roberts
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

5.  Reaction of protein disulfide groups with Ellman's reagent: a case study of the number of sulfhydryl and disulfide groups in Aspergillus oryzae -amylase, papain, and lysozyme.

Authors:  J F Robyt; R J Ackerman; C G Chittenden
Journal:  Arch Biochem Biophys       Date:  1971-11       Impact factor: 4.013

6.  On the rate of a conformation change associated with ligand binding in hemoglobin.

Authors:  E Antonini; M Brunori
Journal:  J Biol Chem       Date:  1969-07-25       Impact factor: 5.157

7.  The rates of reaction of the sulfhydryl groups of human hemoglobin.

Authors:  G Guidotti
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

8.  The structure of human carbonmonoxy haemoglobin at 2.7 A resolution.

Authors:  J M Baldwin
Journal:  J Mol Biol       Date:  1980-01-15       Impact factor: 5.469

9.  Studies on the effect of reagent and protein charges on reactivity of the beta 93 sulfhydryl group of human hemoglobin using selected mutations.

Authors:  B E Hallaway; B E Hedlund; E S Benson
Journal:  Arch Biochem Biophys       Date:  1980-08       Impact factor: 4.013

10.  Conformation and spin state in methemoglobin.

Authors:  P Hensley; S J Edelstein; D C Wharton; Q H Gibson
Journal:  J Biol Chem       Date:  1975-02-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.